SCHEMBL6983419

SCHEMBL6983419

O=C(O)C1(c2cccc3ccccc23)OCC(c2ccccc2)(c2ccccc2)CO1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.38
GSK3B P49841 1/20 0.38
MAPT P10636 3/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
NR4A1 P22736 1/20 0.37
NR4A2 P43354 1/20 0.37
NR4A3 Q92570 1/20 0.37
AKR1C1 Q04828 1/20 0.36
MTNR1A P48039 1/20 0.35
MTNR1B P49286 1/20 0.35
NPC1 O15118 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
RAB9A P51151 1/20 0.35
CXCR5 P32302 1/20 0.35
KIF11 P52732 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6978767 0.89 KMT2A (0.34) KDM4EGSK3BMAPTMEN1KMT2A
SCHEMBL706765 0.83 NR4A1 (0.42) KDM4EMAPTMEN1KMT2ANR4A1
SCHEMBL6981777 0.80 AKR1C1 (0.41) MEN1KMT2AAKR1C1CYP2C9LMNA
SCHEMBL6978773 0.79 KMT2A (0.34) KDM4EGSK3BMEN1KMT2A
SCHEMBL6982681 0.73 THRB (0.44) KDM4EMAPTMEN1KMT2AAKR1C1
SCHEMBL6971603 0.72 CHRNA1 (0.40) KDM4EMAPTMEN1KMT2ANPC1
SCHEMBL6982594 0.72 HSD11B1 (0.39) MEN1KMT2AAKR1C1NPC1CYP3A4
SCHEMBL6978477 0.72 LMNA (0.39) MEN1KMT2AAKR1C1NPC1CYP1A2
SCHEMBL6967893 0.72 CNR1 (0.40) MAPTKMT2AAKR1C1L3MBTL1
SCHEMBL6971207 0.69 OPRM1 (0.44) MAPTKMT2ANPC1RAB9AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1098893-B1 CYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DYSLIPIDEMIA, ATHEROSCLEROSIS AND DIABETES, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PROCESS MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed